Abzena and BioXpress Therapeutics announce partnership to support the development and manufacture of biosimilars for global customers.
Abzena's partnership with BioXpress will allow biosimilar drug developers to benefit from an integrated approach to biosimilars spanning the range from design consultancy, cell line and process development, through to clinical and commercial GMP manufacture.Read More
Watch our webinars on demand!
If you'd like to expand your knowledge on a range of topics from antibody development to pre-formulation, our webinars, hosted by our team of experts, are now available for you on demand.Watch now
Abzena announces location of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors
The significant expansion of Abzena’s capacity is driven by an increase in customer demand for commercial scale 2000L single use bioreactors across a wide range of therapeutic areas.Read More
Technologies and Solutions
Abzena provides proprietary technologies and complementary solutions to organisations involved in the development of biopharmaceutical products.
Latest News and Events
Abzena presents its latest research and exhibits at events all over the world.
Find out where we are next and our latest news below.
Abzena Selects IPS for Turnkey Delivery of Their New CGMP Facility in North Carolina
BIO International 2022
13 June 2022
Abzena announces appointment of Petra Dieterich as Scientific Lead
Resources and Downloads
Find our latest videos, brochures and fact sheets in our resources section.
Download our Brochure
Technology & Solutions BrochureDownload File
Stability of Maleimide-PEG and Mono-Sulfone-PEG Conjugation to a Novel Engineered Cysteine in the Human Hemoglobin Alpha Subunit
In order to use a Hemoglobin Based Oxygen Carrier as an oxygen therapeutic or blood…Read More
Cell Line Development Lab Tour
Abzena has over 10 years experience in Cell Line Development for customers and has completed…